Early Conversion of Intensive Insulin Therapy to IDegLira Demonstrates Higher Efficacy and Safety in Reducing Fasting Blood Glucose and HbA1c in T2DM Patients.
Diabetes Metab Syndr Obes
; 17: 3217-3226, 2024.
Article
in En
| MEDLINE
| ID: mdl-39224113
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Diabetes Metab Syndr Obes
Year:
2024
Document type:
Article
Country of publication:
Nueva Zelanda